Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Regina Scherließ

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Therapeutic Delivery|February 13, 2020
Nasal formulations for drug administration and characterization of nasal preparations in drug deliveryRegina Scherließ
Expert Opinion on Drug Delivery|November 29, 2018
Future of nanomedicines for treating respiratory diseasesRegina Scherließ
International Journal of Pharmaceutics|February 24, 2022
Formulation of rifampicin softpellets for high dose delivery to the lungs with a novel high dose dry powder inhalerChristian Etschmann, Regina Scherließ
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 15, 2025
Investigation of powder properties and application aspects impacting nasal deposition of spray-dried powders in a nasal castAngelika Jüptner, Regina Scherließ
Pharmaceutics|December 28, 2019
Spray Dried Formulations for Inhalation-Meaningful Characterisation of Powder PropertiesAngelika Jüptner, Regina Scherließ
Pharmaceutics|July 29, 2023
Correction: Trenkel, M.; Scherließ, R. Nasal Powder Formulations: In-Vitro Characterisation of the Impact of Powders on Nasal Residence Time and Sensory Effects. <i>Pharmaceutics</i> 2021, <i>13</i>, 385Marie Trenkel, Regina Scherließ
Pharmaceutics|August 4, 2019
Mucosal Vaccination via the Respiratory TractMarie Hellfritzsch, Regina Scherließ
International Journal of Pharmaceutics|June 26, 2018
DPI formulations for high dose applications - Challenges and opportunitiesRegina Scherließ, Christian Etschmann
International Journal of Pharmaceutics|March 14, 2026
Nasal application of spray-dried powders - the impact of filling processes on deposition in a nasal castAngelika Jüptner, Regina Scherließ
Pharmaceutics|August 28, 2021
Preparation of Poly-Lactic-Co-Glycolic Acid Nanoparticles in a Dry Powder Formulation for Pulmonary Antigen DeliveryRegina Scherließ, Julia Janke
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Therapeutic Delivery|February 13, 2020
Nasal formulations for drug administration and characterization of nasal preparations in drug deliveryRegina Scherließ
Expert Opinion on Drug Delivery|November 29, 2018
Future of nanomedicines for treating respiratory diseasesRegina Scherließ
International Journal of Pharmaceutics|February 24, 2022
Formulation of rifampicin softpellets for high dose delivery to the lungs with a novel high dose dry powder inhalerChristian Etschmann, Regina Scherließ
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 15, 2025
Investigation of powder properties and application aspects impacting nasal deposition of spray-dried powders in a nasal castAngelika Jüptner, Regina Scherließ
Pharmaceutics|December 28, 2019
Spray Dried Formulations for Inhalation-Meaningful Characterisation of Powder PropertiesAngelika Jüptner, Regina Scherließ
Pharmaceutics|July 29, 2023
Correction: Trenkel, M.; Scherließ, R. Nasal Powder Formulations: In-Vitro Characterisation of the Impact of Powders on Nasal Residence Time and Sensory Effects. <i>Pharmaceutics</i> 2021, <i>13</i>, 385Marie Trenkel, Regina Scherließ
Pharmaceutics|August 4, 2019
Mucosal Vaccination via the Respiratory TractMarie Hellfritzsch, Regina Scherließ
International Journal of Pharmaceutics|June 26, 2018
DPI formulations for high dose applications - Challenges and opportunitiesRegina Scherließ, Christian Etschmann
International Journal of Pharmaceutics|March 14, 2026
Nasal application of spray-dried powders - the impact of filling processes on deposition in a nasal castAngelika Jüptner, Regina Scherließ
Pharmaceutics|August 28, 2021
Preparation of Poly-Lactic-Co-Glycolic Acid Nanoparticles in a Dry Powder Formulation for Pulmonary Antigen DeliveryRegina Scherließ, Julia Janke
Pageof 7